Total Payments
$2,115
2024 Payments
$131.37
Companies
12
Transactions
23
Medicare Patients
308
Medicare Billing
$21,350
Payment Breakdown by Category
Food & Beverage$2,115 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,115 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $556.37 | 5 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $238.27 | 2 | $0 (2017) |
| Amgen Inc. | $235.00 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $232.47 | 2 | $0 (2020) |
| Allergan Inc. | $190.33 | 2 | $0 (2017) |
| Mallinckrodt Enterprises LLC | $139.57 | 2 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $131.37 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $130.39 | 2 | $0 (2018) |
| Medtronic Vascular, Inc. | $123.04 | 2 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $99.27 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $131.37 | 1 | Actelion Pharmaceuticals US, Inc. ($131.37) |
| 2022 | $18.75 | 1 | Merck Sharp & Dohme LLC ($18.75) |
| 2021 | $222.44 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($222.44) |
| 2020 | $253.04 | 3 | AstraZeneca Pharmaceuticals LP ($232.47) |
| 2019 | $241.34 | 3 | Amgen Inc. ($114.90) |
| 2018 | $819.86 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($227.16) |
| 2017 | $428.60 | 4 | Regeneron Healthcare Solutions, Inc. ($238.27) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $131.37 | General |
| Category: Cardiology | ||||||
| 05/02/2022 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $113.79 | General |
| Category: DIABETES | ||||||
| 06/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $108.65 | General |
| Category: DIABETES | ||||||
| 08/20/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $113.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/18/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $118.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2020 | Mallinckrodt Hospital Products Inc. | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: ACUTE CARE | ||||||
| 10/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $106.77 | General |
| Category: DIABETES | ||||||
| 08/23/2019 | Mallinckrodt Enterprises LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ACUTE CARE | ||||||
| 08/13/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $114.90 | General |
| Category: Cardiology | ||||||
| 11/14/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $112.34 | General |
| Category: DIABETES | ||||||
| 09/11/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $113.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/29/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/24/2018 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $119.90 | General |
| Category: ACUTE CARE | ||||||
| 04/18/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $114.82 | General |
| Category: DIABETES | ||||||
| 03/13/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $120.10 | General |
| Category: Cardiology | ||||||
| 01/30/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/18/2018 | Medtronic Vascular, Inc. | CareLink Express (Device) | Food and Beverage | In-kind items and services | $61.52 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 01/18/2018 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $61.52 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 11/17/2017 | Allergan Inc. | NAMENDA XR (Drug), NAMZARIC | Food and Beverage | In-kind items and services | $84.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $105.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/12/2017 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $119.90 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/21/2017 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $118.37 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 85 | 86 | $40,347 | $6,996 |
| 2022 | 1 | 27 | 29 | $9,800 | $1,660 |
| 2021 | 2 | 102 | 110 | $38,200 | $6,412 |
| 2020 | 3 | 94 | 106 | $36,360 | $6,282 |
Total Patients
308
Total Services
331
Medicare Billing
$21,350
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00142 | Anesthesia for lens surgery | Facility | 2023 | 67 | 68 | $29,127 | $5,053 | 17.3% |
| 00145 | Anesthesia for retinal surgery | Facility | 2023 | 18 | 18 | $11,220 | $1,943 | 17.3% |
| 00142 | Anesthesia for lens surgery | Facility | 2022 | 27 | 29 | $9,800 | $1,660 | 16.9% |
| 00142 | Anesthesia for lens surgery | Facility | 2021 | 77 | 83 | $28,600 | $4,894 | 17.1% |
| 01936 | Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | Facility | 2021 | 25 | 27 | $9,600 | $1,518 | 15.8% |
| 01936 | Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | Facility | 2020 | 69 | 81 | $27,900 | $4,859 | 17.4% |
| 00142 | Anesthesia for lens surgery | Facility | 2020 | 11 | 11 | $4,140 | $727.98 | 17.6% |
| 01992 | Anesthesia for nerve block and injection procedure, prone position | Facility | 2020 | 14 | 14 | $4,320 | $695.20 | 16.1% |
About Dr. Manjula Mistry, M.D
Dr. Manjula Mistry, M.D is a Anesthesiology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952365330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manjula Mistry, M.D has received a total of $2,115 in payments from pharmaceutical and medical device companies, with $131.37 received in 2024. These payments were reported across 23 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,115).
As a Medicare-enrolled provider, Mistry has provided services to 308 Medicare beneficiaries, totaling 331 services with total Medicare billing of $21,350. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Location Cleveland, OH
- Active Since 04/13/2006
- Last Updated 02/07/2008
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1952365330
Products in Payments
- JARDIANCE (Drug) $556.37
- PRALUENT ALIROCUMAB INJECTION (Biological) $238.27
- Repatha (Biological) $235.00
- OFIRMEV (Drug) $160.14
- UPTRAVI (Drug) $131.37
- XARELTO (Drug) $130.39
- FARXIGA (Drug) $118.79
- LOKELMA (Drug) $113.68
- LINZESS (Drug) $105.52
- XIFAXAN (Drug) $99.27
- NAMENDA XR (Drug) $84.81
- CareLink Express (Device) $61.52
- Reveal LINQ (Device) $61.52
- BRIDION (Drug) $18.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Cleveland
Sabry Ayad, M.d, M.D
Anesthesiology — Payments: $632,587
Anesthesiology $632,587
Dr. Edwin Avery, Md, MD
Anesthesiology — Payments: $376,267
Anesthesiology $376,267
Daniel Sessler, M.d, M.D
Anesthesiology — Payments: $342,890
Anesthesiology $342,890
Andrew Shaw, Md, MD
Anesthesiology — Payments: $148,627
Anesthesiology $148,627
Peter Schoenwald, Md, MD
Anesthesiology — Payments: $140,951
Anesthesiology $140,951
Hesham Elsharkawy, M.d, M.D
Anesthesiology — Payments: $134,336
Anesthesiology $134,336